









Markets
/
Stocks
/
nasdaq-drio
/

DarioHealth Corp

DRIO

13.590USD

+0.090+0.67%

Close 11/05, 16:00（ET）Quotes delayed by 15 min

30.90MMarket Cap

LossP/E TTM



DarioHealth Corp

13.590

+0.090+0.67%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of DarioHealth Corp

Currency: USD Updated: 2025-11-05

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

DarioHealth Corp's Score

Industry at a Glance

Industry Ranking

127 / 210

Overall Ranking

285 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Buy

Current Rating

22.250

Target Price

+64.81%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

DarioHealth Corp Highlights

StrengthsRisks

DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Growing

The company is in a growing phase, with the latest annual income totaling USD 27.04M.

Fairly Valued

The company’s latest PE is -0.86, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 331.14K shares, decreasing 43.96% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 6.49K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-05

The company's current financial score is 5.61, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 5.37M, representing a year-over-year decrease of 14.16%, while its net profit experienced a year-over-year decrease of 79.01%.

Score

Industry at a Glance

Previous score

5.61

Change



Financials

6.65

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.15

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.57

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

4.59

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.11

Key Metrics

Free cash flow

No Data

DarioHealth Corp's Company Valuation

Currency: USD Updated: 2025-11-05

The company’s current valuation score is 7.51, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -0.86, which is -96.85% below the recent high of -0.03 and -166.82% above the recent low of -2.30.

Score

Industry at a Glance

Previous score

7.51

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 127/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-05

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for DarioHealth Corp is 25.00, with a high of 27.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Buy

Current Rating

22.250

Target Price

+64.81%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

DarioHealth Corp

DRIO

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-05

The company’s current price momentum score is 7.20, which is higher than the Healthcare Equipment & Supplies industry's average of 6.82. Sideways: Currently, the stock price is trading between the resistance level at 16.02 and the support level at 11.69, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.18

Change

0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.891

Neutral

RSI(14)

49.500

Neutral

STOCH(KDJ)(9,3,3)

14.219

Oversold

ATR(14)

1.272

High Vlolatility

CCI(14)

-85.281

Neutral

Williams %R

67.991

Sell

TRIX(12,20)

0.423

Sell

StochRSI(14)

20.118

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

13.696

Sell

MA10

14.486

Sell

MA20

14.503

Sell

MA50

12.113

Buy

MA100

6.365

Buy

MA200

3.524

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-05

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.40. The latest institutional shareholding proportion is 9.32%, representing a quarter-over-quarter decrease of 75.84%. The largest institutional shareholder is The Vanguard, holding a total of 18.18K shares, representing 0.51% of shares outstanding, with 52.03% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Raphael (Erez)

152.43K

+64.91%

Solid Financial LLC

106.98K

+20.64%

Tasso Partners, LLC

88.14K

-0.40%

Nantahala Capital Management, LLC

84.61K

Appian Way Asset Management LP

64.04K

Phoenix Investment and Finances Ltd

56.34K

Nelson (Steven Charles)

43.08K

+229.31%

Stern (Adam K.)

34.99K

+133.44%

Ben-David (Zvi)

34.89K

+4.95%

Shaked (Yoav)

33.03K

+153.46%

Risk Assessment

Currency: USD Updated: 2025-11-05

The company’s current risk assessment score is 1.04, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.07. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.